| Literature DB >> 28207882 |
Bernd Carsten Stahl1, Kutoma Wakunuma1, Stephen Rainey1, Christian Hansen1.
Abstract
Research on Brain Computer Interfaces (BCI) often aims to provide solutions for vulnerable populations, such as individuals with diseases, conditions or disabilities that keep them from using traditional interfaces. Such research thereby contributes to the public good. This contribution to the public good corresponds to a broader drive of research and funding policy that focuses on promoting beneficial societal impact. One way of achieving this is to engage with the public. In practical terms this can be done by integrating civil society organisations (CSOs) in research. The open question at the heart of this paper is whether and how such CSO integration can transform the research and contribute to the public good. To answer this question the paper describes five detailed qualitative case studies of research projects including CSOs. The paper finds that transformative impact of CSO integration is possible but by no means assured. It provides recommendations on how transformative impact can be promoted.Entities:
Mesh:
Year: 2017 PMID: 28207882 PMCID: PMC5313172 DOI: 10.1371/journal.pone.0171818
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Graphical representation of components of transformativity.
General scheme for assessing transformativity.
| Researcher | CSO | Other (companies or funder) | |
|---|---|---|---|
| Expectations | |||
| Technology | |||
| Assessment | |||
| Role |
Data on case study projects.
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
|---|---|---|---|---|---|
| Funding source | National research council- Significant co-funding from CSOs (~€400k) and in-kind contribution from industry | National research funding council | EU FP7 | EU FP7 | EU FP7 |
| Budget | n/a | Overall over €20m with a funding contribution of €10m | €3M with funding contribution of €2.3M | € 3.2M with funding contribution of € 2.5M | € 4M 186 248 with funding contribution of € 3 M |
| Data collected | interviews (Proposal writer-academic researcher Project manager CSO President PI-senior researcher Additional interview with proposal writer Project website Project brochure | interviews (Principal Investigator Sub-project coordinator Senior researcher Industry partner CSO partner) Project final report Project website Journal publication on ethics and the research Project brochure | interviews with 5 respondents (CSO number 1 employee Project coordinator Researcher and WP leader 2 CSO number 2 employees) 9 publicly available deliverables 4 dissemination documents (booklet, publishable summary, poster) project press releases 19 publications 3 videos Project website, consisting of 19 pdf documents Funding call ICT 2009–4 | 3 interviews (Project Coordinator CSO Researcher Project call Media coverage Deliverables Publications Promotional material | 4 interviews (CSO Technical Industry Representative Academic Scientist Project Coordinator Project website |
| Timing of data collection | Between 23.01.2013 and 08.08.2013 | Between 20.12.2012 and 01.03.2013 | Between 18.03.2013 and 16.05.2013 | Between 22.04.2013 and 20.09.2013 | Between 01.07.2013 and 10.04.2014 |
Summary of case 1.
| Researcher | CSO | Funder | |
|---|---|---|---|
Academic research outcomes, specifically 4 PhDs in the area under research | Customised BCI technology for Duchenne sufferers | Applied and market oriented research outcomes | |
Purely focussed research on the subject under investigation in order to have some publications on the possibilities of the technology | Technology intended to relieve the suffering of Duchenne sufferers | Technology to have practical applications to the outside world Technology to be commercially viable | |
End-user involvement | End-user feedback | N/A | |
Research | Co-funder Project initiators Creation of organisation for proposal writing Proposal writing Research agenda setting | National research funder |
Summary of case 2.
| Researcher | CSO | Funder / Industry | |
|---|---|---|---|
The development of neurological stimulation methods in addition to assisting in the development of software to predict current flow in the brain. To undertake more scientific theoretically based research about brain functions. To undertake research that would be attractive to industry in order that it can be packaged as a product For the patient organisations to assist in user tests and application in the specific patient ailment. To have more CSO involvement as a way of winning scarce funding. To realise more informed societal input in research. | Manifest outcomes, partly because of the high importance of “valorisation” in the project. To make an immediate difference to the quality of life of their constituents. Specific funds to be allocated to solving specific problems | Impact of research on society Reduced animal testing Involvement of patients Creation of innovative products. | |
Technology as a means of proving scientific hypotheses. In the second instance, technology as a product to be used by patients | Technology as practical help for the patients the CSOs represent; this was not realised. | Technical products on the market (not realised) Social impact of research | |
Relied on scientific evaluation of project through project review; assessment of findings through scientific peer review. | Practical testing of technologies with users | Project review; valorisation panel looking at broader societal impact | |
Leader, organiser and most active partner. | Link to end users; Required CSO inclusion according to funding call No official role, no deliverables | The consortium included companies but this did not lead to a commercial product by the end of the project life cycle. |
Summary of case 3.
| Researcher | CSO | Funder / Industry | |
|---|---|---|---|
development of BCI technologies and achieving further scientific excellence publish in high quality outlets | Test the device on their constituents, i.e. individuals with severe brain or spinal cord injury | Focuses on the benefit for the eventual user of the technology expected impact underlines the economic aspect of the development | |
Expected to develop a prototype, not a product | Technology could not be tested due to lack of portability CSO1 remained unconvinced of practical applicability | Agnostic on actual technology; focus on benefit for users and economic benefits | |
Success of project and technology development to be measured by peer reviewed publications | Test of actual technology in real-life conditions (did not happen) | General project review mechanisms; based on external expert (scientific) review | |
Coordinator, main driver; the coordinator was not the leading scientist | User testing | Companies aimed to promote product development |
Summary of case 4.
| Researcher | CSO | Funder/Industry | |
|---|---|---|---|
Actual technology product for sufferers of a degenerative disease in in order to improve their communication and social skills | A better integration of sufferers in everyday environments such as schools due to the intervention of the technology. Additionally, a desire not to put too much reliance on the technology but on understanding actual patient needs and problems | Funder: High importance placed on end-user participation particularly on patients and professionals like physiotherapists and rehabilitators who might potentially use the end product Industry: aimed at having better portfolio for companies they work for | |
Development of physical technological product | Emphasis not on the actual end product but on product capabilities in alleviating sufferers inability to communicate and be socially adept | Industry: Development of better sensors as a result of the project | |
Testing of the product on end-users as a way of seeing its viability | Feedback on product after end-user tests Dissemination | Commercial viability of product | |
Research and production of technology | Proposal writing End-user testing and dissemination WPs | Funders pushed for end-user participation Industry facilitates transition of the prototypes to commercial products |
Summary of case 5.
| Researcher | CSO | Funder | |
|---|---|---|---|
Make inroads in BCI research in order to alleviate patient suffering where patients have no autonomy to carry out everyday activities independently. Cultivation of new topics in order to advance the field of BCI research. Scientific publications | A realisation of positive results for disabled people. Particular interest in advancing research in the field of BCI | To advance research excellence in the field of BCI | |
Development of a tele-monitoring home system | Technology to advance well-being of patients | Industry: Commercial viability of the technology | |
Viability of technology through feedback from users | End user testing and feedback | ||
Coordination Lead scientist | Intermediary and link to interest patient groups and provide patient access to the researchers and technology developers for testing and feedback purposes. Linking industry to the end-users | Bringing a commercial angle as a way of making the product commercial read |
Fig 2Graphical representation of the factors influencing the level of transformativity of CSO inclusion.